- Entry
- $16.26
- Final
- $1.98 -87.8%
- Target
- —
- Score
- -1.00
Ok, bit of a theme with my last couple of posts also being biotech plays. I'm not a biotech guy, these have come up on my scanner and are pretty interesting setups. Tenax Therapeutics (TENX) is effectively a one-drug biotech. The drug is oral levosimendan (licensed from Finland's Orion Corporation) for PH-HFpEF, a common form of high blood pressure in the lungs tied to a type of heart failure, with no approved treatment anywhere. There's a second program (imatinib for …
— ORIGINAL POST ·
TENX: Tenax Therapeutics. Fully-enrolled Phase 3. Results due August. $119M cash, no debt. Another binary biotech play (kinda)
· r/pennystocks
· Jul 6, 2026